206 related articles for article (PubMed ID: 19567354)
1. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).
Pagano L; Valentini CG; Posteraro B; Girmenia C; Ossi C; Pan A; Candoni A; Nosari A; Riva M; Cattaneo C; Rossini F; Fianchi L; Caira M; Sanguinetti M; Gesu GP; Lombardi G; Vianelli N; Stanzani M; Mirone E; Pinsi G; Facchetti F; Manca N; Savi L; Mettimano M; Selva V; Caserta I; Scarpellini P; Morace G; D'Arminio Monforte A; Grossi P; Giudici D; Tortorano AM; Bonini A; Ricci L; Picardi M; Rossano F; Fanci R; Pecile P; Fumagalli L; Ferrari L; Capecchi PL; Romano C; Busca A; Barbui A; Garzia M; Minniti RR; Farina G; Montagna MT; Bruno F; Morelli O; Chierichini A; Placanica PM; Castagnola E; Bandettini R; Giordano S; Monastero R; Tosti ME; Rossi MR; Spedini P; Piane R; Nucci M; Pallavicini F; Bassetti M; Cristini F; LA Sorda M; Viviani M
J Chemother; 2009 Jun; 21(3):322-9. PubMed ID: 19567354
[TBL] [Abstract][Full Text] [Related]
2. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.
Skiada A; Pagano L; Groll A; Zimmerli S; Dupont B; Lagrou K; Lass-Florl C; Bouza E; Klimko N; Gaustad P; Richardson M; Hamal P; Akova M; Meis JF; Rodriguez-Tudela JL; Roilides E; Mitrousia-Ziouva A; Petrikkos G;
Clin Microbiol Infect; 2011 Dec; 17(12):1859-67. PubMed ID: 21199154
[TBL] [Abstract][Full Text] [Related]
3. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases.
Shoham S; Magill SS; Merz WG; Gonzalez C; Seibel N; Buchanan WL; Knudsen TA; Sarkisova TA; Walsh TJ
Med Mycol; 2010 May; 48(3):511-7. PubMed ID: 19824881
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B
Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440
[TBL] [Abstract][Full Text] [Related]
5. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA
J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological aspects and clinical outcome of patients with Rhinocerebral zygomycosis: a survey in a referral hospital in Iran.
Bozorgi V; Talebitaher M; Shalbaf N; Radmanesh N; Nasri F; Ansari-Ramandi MM
Pan Afr Med J; 2016; 24():232. PubMed ID: 27800087
[TBL] [Abstract][Full Text] [Related]
7. Invasive zygomycosis in India: experience in a tertiary care hospital.
Chakrabarti A; Chatterjee SS; Das A; Panda N; Shivaprakash MR; Kaur A; Varma SC; Singhi S; Bhansali A; Sakhuja V
Postgrad Med J; 2009 Nov; 85(1009):573-81. PubMed ID: 19892892
[TBL] [Abstract][Full Text] [Related]
8. Global epidemiology of cutaneous zygomycosis.
Skiada A; Rigopoulos D; Larios G; Petrikkos G; Katsambas A
Clin Dermatol; 2012; 30(6):628-32. PubMed ID: 23068150
[TBL] [Abstract][Full Text] [Related]
9. Zygomycosis in children: a systematic review and analysis of reported cases.
Zaoutis TE; Roilides E; Chiou CC; Buchanan WL; Knudsen TA; Sarkisova TA; Schaufele RL; Sein M; Sein T; Prasad PA; Chu JH; Walsh TJ
Pediatr Infect Dis J; 2007 Aug; 26(8):723-7. PubMed ID: 17848885
[TBL] [Abstract][Full Text] [Related]
10. Improved outcome of zygomycosis in patients with hematological diseases?
Gleissner B; Schilling A; Anagnostopolous I; Siehl I; Thiel E
Leuk Lymphoma; 2004 Jul; 45(7):1351-60. PubMed ID: 15359632
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of cutaneous zygomycosis.
Visser DH; van den Berg YL; van Furth AM; Oomen MW; Schouten-van Meeteren AY; Pajkrt D; van den Bos C; van Well GT
Pediatr Infect Dis J; 2007 Dec; 26(12):1165-6. PubMed ID: 18043463
[TBL] [Abstract][Full Text] [Related]
12. Ten years' experience in zygomycosis at a tertiary care centre in India.
Chakrabarti A; Das A; Sharma A; Panda N; Das S; Gupta KL; Sakhuja V
J Infect; 2001 May; 42(4):261-6. PubMed ID: 11545569
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Trifilio SM; Bennett CL; Yarnold PR; McKoy JM; Parada J; Mehta J; Chamilos G; Palella F; Kennedy L; Mullane K; Tallman MS; Evens A; Scheetz MH; Blum W; Kontoyiannis DP
Bone Marrow Transplant; 2007 Apr; 39(7):425-9. PubMed ID: 17310132
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
Roden MM; Zaoutis TE; Buchanan WL; Knudsen TA; Sarkisova TA; Schaufele RL; Sein M; Sein T; Chiou CC; Chu JH; Kontoyiannis DP; Walsh TJ
Clin Infect Dis; 2005 Sep; 41(5):634-53. PubMed ID: 16080086
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of zygomycosis and their related factors in tertiary referral centers in southern Iran.
Badiee P; Jafarian H; Ghasemi F
J Infect Dev Ctries; 2020 Dec; 14(12):1424-1430. PubMed ID: 33378285
[TBL] [Abstract][Full Text] [Related]
16. [Invasive zygomycosis in patients treated for haematological malignancies].
Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
[TBL] [Abstract][Full Text] [Related]
17. Zygomycoses in patients with acute leukaemia.
Schalk E; Mohren M; Jentsch-Ullrich K; Dombrowski F; Franke A; Koenigsmann M
Ann Hematol; 2006 May; 85(5):327-32. PubMed ID: 16523312
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic challenge of zygomycosis in compromised hosts.
Wang JL; Hsiao CH; Chang SC; Hsueh PR; Chen YC
Med Mycol; 2006 Feb; 44(1):19-24. PubMed ID: 16805089
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous zygomycosis.
Skiada A; Petrikkos G
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():41-5. PubMed ID: 19754756
[TBL] [Abstract][Full Text] [Related]
20. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Chamilos G; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
